Curam 625 Mg 12 Tablets

Curam 625 Mg 12 Tablets

Description:

Curam 625 mg 12 tablets is a prescription systemic antibiotic medication containing amoxicillin and clavulanic acid, used to treat a wide range of bacterial infections. It belongs to the beta-lactam/penicillin class and is specifically formulated to overcome resistance caused by beta-lactamase–producing bacteria. Curam 625 mg is commonly prescribed for respiratory tract infections, sinus infections, ear infections, skin and soft tissue infections, and urinary tract infections in adults and adolescents, as directed by a healthcare professional.

Indications:

• Lower respiratory tract infections, including acute exacerbations of chronic bronchitis and pneumonia, caused by beta-lactamase–producing isolates of Haemophilus influenzae and Moraxella catarrhalis.
• Acute bacterial otitis media (middle ear infection) caused by beta-lactamase–producing isolates of Haemophilus influenzae and Moraxella catarrhalis.
• Acute bacterial sinusitis caused by beta-lactamase–producing isolates of Haemophilus influenzae and Moraxella catarrhalis.
• Skin and skin structure infections caused by beta-lactamase–producing isolates of Staphylococcus aureus, Escherichia coli, and Klebsiella species.
• Urinary tract infections (uncomplicated and certain complicated infections) caused by beta-lactamase–producing isolates of Escherichia coli, Klebsiella species, and Enterobacter species.
• Other susceptible infections as determined by culture, sensitivity testing, and physician judgment.

Active Ingredients / Key Components:

• Amoxicillin (as amoxicillin trihydrate) – 500 mg per film-coated tablet (exact salt form and amount may vary by manufacturer; detailed composition not provided on label here).
• Clavulanic acid (as potassium clavulanate) – 125 mg per film-coated tablet (exact salt form and amount may vary by manufacturer; detailed composition not provided on label here).
• Total strength: 625 mg per film-coated tablet (amoxicillin + clavulanic acid).
• Excipients: film-coating agents, fillers, binders, and stabilizers (full excipient list and concentrations , please check the product leaflet or the manufacturer’s official website).

Dosage & Administration / How to Use:

• Curam 625 mg tablets are for oral use only and must be taken exactly as prescribed by your doctor.
• Adults and adolescents (and children of sufficient weight, as directed by a physician): the usual dose is 1 tablet of Curam 625 mg every 8–12 hours, depending on the type and severity of infection and renal function. The exact regimen must be determined by the prescribing physician.
• Take the tablet with a meal or snack to improve absorption and help reduce gastrointestinal side effects such as nausea and stomach upset.
• Swallow the tablet whole with a glass of water. Do not crush or chew unless your doctor advises otherwise.
• Duration of treatment typically ranges from 5 to 14 days, depending on the infection. Do not stop treatment early, even if you feel better, unless instructed by your doctor, as this may lead to recurrence or antibiotic resistance.
• If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose to make up for a missed one.
• Use in children: dosing is usually based on body weight and infection severity and may require different strengths or formulations. Always follow pediatric dosing instructions from a healthcare professional.
• Patients with kidney or liver impairment may require dose adjustment or extended dosing intervals. Use only under strict medical supervision in these cases.

Clinical Benefits:

• Broad-spectrum antibacterial activity: combines amoxicillin with clavulanic acid to cover a wide range of gram-positive and gram-negative bacteria, including beta-lactamase–producing strains.
• Overcomes resistance: clavulanic acid inhibits many beta-lactamase enzymes, helping amoxicillin remain effective against resistant organisms.
• Effective for common respiratory infections: provides targeted treatment for sinusitis, otitis media, and lower respiratory tract infections caused by susceptible bacteria.
• Suitable for mixed and complicated infections: useful in skin, soft tissue, and urinary tract infections where multiple organisms or resistant strains may be involved.

Warnings & Contraindications:

• Contraindicated in patients with a known hypersensitivity (allergy) to amoxicillin, clavulanic acid, other penicillins, or any component of the formulation.
• Use with extreme caution in patients with a history of severe allergic reactions to beta-lactam antibiotics (e.g., cephalosporins, carbapenems), including anaphylaxis, angioedema, or severe skin reactions.
• Patients with hepatic dysfunction or a history of amoxicillin–clavulanate–associated jaundice or hepatic impairment should not use this product unless clearly needed and under close medical supervision.
• Use with caution in patients with renal impairment; dose adjustment and monitoring may be necessary.
• Prolonged use may result in overgrowth of non-susceptible organisms, including fungi; if superinfection occurs, appropriate therapy should be instituted.
• May reduce the effectiveness of oral contraceptives; additional non-hormonal contraceptive measures are advisable during therapy.
• Inform your doctor about all medications you are taking, especially anticoagulants (e.g., warfarin), methotrexate, allopurinol, or other antibiotics, due to potential interactions.
• Pregnancy and breastfeeding: use only if clearly needed and prescribed by a doctor after assessing risks and benefits.
• Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as kidney disease, liver disease, mononucleosis, or a history of severe allergies or asthma.
• Keep out of reach of children.

Side Effects:

• Common side effects: nausea, vomiting, diarrhea, abdominal discomfort, soft stools, and mild skin rash.
• Less common side effects: headache, dizziness, oral or vaginal candidiasis (thrush), and changes in taste.
• Serious side effects (seek immediate medical attention): severe allergic reactions (rash, itching, swelling of face/lips/tongue/throat, difficulty breathing), severe skin reactions (Stevens–Johnson syndrome, toxic epidermal necrolysis), persistent or bloody diarrhea (possible Clostridioides difficile–associated colitis), yellowing of the skin or eyes (jaundice), dark urine, severe abdominal pain, or unusual bruising/bleeding.
• If any side effect is severe, persistent, or concerning, stop the medication and contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and moisture. Keep the blister pack in the outer carton to protect from light. Do not store above the temperature specified on the package (typically below 25°c; exact storage temperature is not provided in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.)). Keep container tightly closed and keep out of reach of children. Do not use after the expiry date printed on the pack.

Specifications:

• Product type: systemic antibiotic medicine (amoxicillin + clavulanic acid).
• Strength: 625 mg per film-coated tablet (amoxicillin + clavulanic acid).
• Form: film-coated tablet for oral use.
• Pack size: 12 tablets per pack.
• Intended use: treatment of susceptible bacterial infections as prescribed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.